261 related articles for article (PubMed ID: 17964138)
1. Integration of progesterone receptor action with rapid signaling events in breast cancer models.
Lange CA
J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):203-12. PubMed ID: 17964138
[TBL] [Abstract][Full Text] [Related]
2. Integration of rapid signaling events with steroid hormone receptor action in breast and prostate cancer.
Lange CA; Gioeli D; Hammes SR; Marker PC
Annu Rev Physiol; 2007; 69():171-99. PubMed ID: 17037979
[TBL] [Abstract][Full Text] [Related]
3. Progesterone receptor action: translating studies in breast cancer models to clinical insights.
Lange CA; Sartorius CA; Abdel-Hafiz H; Spillman MA; Horwitz KB; Jacobsen BM
Adv Exp Med Biol; 2008; 630():94-111. PubMed ID: 18637487
[TBL] [Abstract][Full Text] [Related]
4. Making sense of cross-talk between steroid hormone receptors and intracellular signaling pathways: who will have the last word?
Lange CA
Mol Endocrinol; 2004 Feb; 18(2):269-78. PubMed ID: 14563938
[TBL] [Abstract][Full Text] [Related]
5. Integration of progesterone receptor mediated rapid signaling and nuclear actions in breast cancer cell models: role of mitogen-activated protein kinases and cell cycle regulators.
Faivre E; Skildum A; Pierson-Mullany L; Lange CA
Steroids; 2005; 70(5-7):418-26. PubMed ID: 15862825
[TBL] [Abstract][Full Text] [Related]
6. Progesterone receptor-cyclin D1 complexes induce cell cycle-dependent transcriptional programs in breast cancer cells.
Dressing GE; Knutson TP; Schiewer MJ; Daniel AR; Hagan CR; Diep CH; Knudsen KE; Lange CA
Mol Endocrinol; 2014 Apr; 28(4):442-57. PubMed ID: 24606123
[TBL] [Abstract][Full Text] [Related]
7. Progesterone receptors upregulate Wnt-1 to induce epidermal growth factor receptor transactivation and c-Src-dependent sustained activation of Erk1/2 mitogen-activated protein kinase in breast cancer cells.
Faivre EJ; Lange CA
Mol Cell Biol; 2007 Jan; 27(2):466-80. PubMed ID: 17074804
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression.
Knutson TP; Daniel AR; Fan D; Silverstein KA; Covington KR; Fuqua SA; Lange CA
Breast Cancer Res; 2012 Jun; 14(3):R95. PubMed ID: 22697792
[TBL] [Abstract][Full Text] [Related]
9. Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs.
Knutson TP; Truong TH; Ma S; Brady NJ; Sullivan ME; Raj G; Schwertfeger KL; Lange CA
J Hematol Oncol; 2017 Apr; 10(1):89. PubMed ID: 28412963
[TBL] [Abstract][Full Text] [Related]
10. Linkage of progestin and epidermal growth factor signaling: phosphorylation of progesterone receptors mediates transcriptional hypersensitivity and increased ligand-independent breast cancer cell growth.
Daniel AR; Qiu M; Faivre EJ; Ostrander JH; Skildum A; Lange CA
Steroids; 2007 Feb; 72(2):188-201. PubMed ID: 17173941
[TBL] [Abstract][Full Text] [Related]
11. Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors.
Faivre EJ; Daniel AR; Hillard CJ; Lange CA
Mol Endocrinol; 2008 Apr; 22(4):823-37. PubMed ID: 18202149
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294.
Shen T; Horwitz KB; Lange CA
Mol Cell Biol; 2001 Sep; 21(18):6122-31. PubMed ID: 11509655
[TBL] [Abstract][Full Text] [Related]
13. Progesterone receptors act as sensors for mitogenic protein kinases in breast cancer models.
Dressing GE; Hagan CR; Knutson TP; Daniel AR; Lange CA
Endocr Relat Cancer; 2009 Jun; 16(2):351-61. PubMed ID: 19357196
[TBL] [Abstract][Full Text] [Related]
14. Role of phosphorylation in progesterone receptor signaling and specificity.
Hagan CR; Daniel AR; Dressing GE; Lange CA
Mol Cell Endocrinol; 2012 Jun; 357(1-2):43-9. PubMed ID: 21945472
[TBL] [Abstract][Full Text] [Related]
15. Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases.
Skildum A; Faivre E; Lange CA
Mol Endocrinol; 2005 Feb; 19(2):327-39. PubMed ID: 15486045
[TBL] [Abstract][Full Text] [Related]
16. Convergence of progesterone and epidermal growth factor signaling in breast cancer. Potentiation of mitogen-activated protein kinase pathways.
Lange CA; Richer JK; Shen T; Horwitz KB
J Biol Chem; 1998 Nov; 273(47):31308-16. PubMed ID: 9813039
[TBL] [Abstract][Full Text] [Related]
17. 90 YEARS OF PROGESTERONE: Steroid receptors as MAPK signaling sensors in breast cancer: let the fates decide.
Dwyer AR; Truong TH; Ostrander JH; Lange CA
J Mol Endocrinol; 2020 Jul; 65(1):T35-T48. PubMed ID: 32209723
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation-dependent antagonism of sumoylation derepresses progesterone receptor action in breast cancer cells.
Daniel AR; Faivre EJ; Lange CA
Mol Endocrinol; 2007 Dec; 21(12):2890-906. PubMed ID: 17717077
[TBL] [Abstract][Full Text] [Related]
19. Distinct molecular pathways mediate progesterone-induced growth inhibition and focal adhesion.
Lin VC; Woon CT; Aw SE; Guo C
Endocrinology; 2003 Dec; 144(12):5650-7. PubMed ID: 12970168
[TBL] [Abstract][Full Text] [Related]
20. Receptor mechanisms of rapid extranuclear signalling initiated by steroid hormones.
Boonyaratanakornkit V; Edwards DP
Essays Biochem; 2004; 40():105-20. PubMed ID: 15242342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
